Trellis Bioscience
San Francisco · Founded 1998
About Trellis Bioscience
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
Company Facts
- Founded: 1998
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $28.6M
- Last round: Series Unknown (Oct 2024)
- Website: trellisbio.com
- Phone: (650)616-1100
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/trellis-bioscience-2459 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.